Total raised
—
Last: Undisclosed 2025-05
Stage
Seed
Founded
2025
Headcount
2
HQ
Or Yehuda
Sector
Health Tech & Life Sciences
About
EndoPulse is a medical device company developing the next generation of life-saving cardiac support. The company's mission is to enhance outcomes for patients with critical cardiac conditions by pioneering a solution that addresses the known limitations of current technologies. Backed by an experienced leadership team and a strategic intellectual property roadmap, we are focused on setting a new standard of care and significantly improving patient outcomes.
Funding history · 1 round · — total
2025-05
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was EndoPulse founded?
- EndoPulse was founded in April 2025.
- What is EndoPulse's primary focus?
- EndoPulse is a medical device company developing life-saving cardiac support technology to enhance outcomes for patients with critical cardiac conditions.
- Where is EndoPulse headquartered?
- EndoPulse is headquartered in Or Yehuda, Israel.
- Which investor participated in EndoPulse's May 2025 funding round?
- Peregrine Ventures participated in an undisclosed funding round for EndoPulse in May 2025.
- What is EndoPulse's current funding stage?
- EndoPulse is currently in the Seed funding stage.
- How many employees does EndoPulse currently have?
- EndoPulse currently has 1-10 employees.
- Who is a co-founder of EndoPulse?
- Ben Friesem is a co-founder of EndoPulse.
- What sector does EndoPulse operate in?
- EndoPulse operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Life Support.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cardiology